P. R and S. Bashir, “CRITICAL REVIEW OF PHARMACOGENOMICS IN ANTIPARKINSONIAN DRUG THERAPY: IMPACT ON CLINICAL MANAGEMENT OF PARKINSON’S DISEASE”, Asian J Pharm Clin Res, vol. 9, no. 6, pp. 24–27, Nov. 2016.